Seller record · Telehealth service

Bodi Envi

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 1 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published on the treatment pages, the answers page or the policies.

At a glance

Bodi EnviTelehealth service

7/8criteria passed

Price: Semaglutide $155 a month intro offer (regular $179), tirzepatide $229 (regular $249)
Sells: personalized compounded semaglutide, personalized compounded tirzepatide, and 4 more
FDA letters: None on file

Visit Bodi Envi See all eight dispositions

Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.

A Tampa telehealth service selling compounded semaglutide and tirzepatide at one monthly price for every dose, lower-dose microdosing plans, NAD+ injections and anti-nausea support. Care comes from a physician group, and prescriptions are filled by VialsRx in Houston.

Operating entity Bodi Envi, LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Bodi Envi's FAQ; Bodi Envi's how it works page
S2	Prescription gating	PASS	Bodi Envi's website; Bodi Envi's weight loss page; Bodi Envi's refund policy
S3	Pharmacy identification	PASS	Bodi Envi's FAQ; Bodi Envi's contact page
S4	Compounding disclosure	PASS	Bodi Envi's FAQ; Bodi Envi's compound semaglutide page
S5	Analytical documentation	FAIL	Bodi Envi's weight loss page; Bodi Envi's FAQ
S6	Business address	PASS	Bodi Envi's hhippa page; Bodi Envi's contact page
S7	Price disclosure	PASS	Bodi Envi's compound semaglutide page; Bodi Envi's compound tirzepatide injections page; Bodi Envi's weight loss page; Bodi Envi's micro dose semaglutide page; Bodi Envi's micro dose tirzepatide page; Bodi Envi's NAD+ page; Bodi Envi's ondansetron page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed healthcare provider reviews each patient's medical information and decides whether treatment is appropriate, and the answers page names Wasef Health, PC as the clinical provider organization, with a board-certified internal medicine physician as medical director.Source: Bodi Envi's FAQ; Bodi Envi's how it works page.

S2PASSThe home page and the treatment pages say the buyer completes a quick intake first and the team reviews the information before any purchase. The refund policy keeps a $50 consultation fee if an order is canceled after a prescription is issued.Source: Bodi Envi's website; Bodi Envi's weight loss page; Bodi Envi's refund policy.

S3PASSThe answers on every page name VialsRx as the current pharmacy partner for GLP-1 prescriptions, at 6220 Westpark Drive, Suite 111, Houston, TX 77057.Source: Bodi Envi's FAQ; Bodi Envi's contact page.

S4PASSEvery page states that compounded semaglutide and tirzepatide have not been approved by the FDA or reviewed for safety, effectiveness or quality, and the answers page says compounded semaglutide is a different category of product from the FDA-approved ones.Source: Bodi Envi's FAQ; Bodi Envi's compound semaglutide page.

S5FAILNo certificate of analysis or lot document is published on the treatment pages, the answers page or the policies.Source: Bodi Envi's weight loss page; Bodi Envi's FAQ.

S6PASSBodi Envi, LLC at 6904 W Linebaugh Ave, Tampa, 33625, printed in the privacy notice and on the contact page.Source: Bodi Envi's hhippa page; Bodi Envi's contact page.

S7PASSCompounded semaglutide at $155 a month for all doses as an intro offer against a regular price of $179, and compounded tirzepatide at $229 against $249, each shown with a countdown; the weight loss page prints $155 and $229 a month with no other figure. Microdose semaglutide at $169 a month, $477 a quarter or $894 for six months, and microdose tirzepatide at $249, $717 or $1374. NAD+ at a flat $130 a month and ondansetron from $99.Source: Bodi Envi's compound semaglutide page; Bodi Envi's compound tirzepatide injections page; Bodi Envi's weight loss page; Bodi Envi's micro dose semaglutide page; Bodi Envi's micro dose tirzepatide page; Bodi Envi's NAD+ page; Bodi Envi's ondansetron page.

S8PASSNo FDA warning letter names Bodi Envi, Bodi Envi, LLC or Wasef Health, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: personalized compounded semaglutide, personalized compounded tirzepatide, micro-dose compounded semaglutide, micro-dose compounded tirzepatide, NAD+ injection, compounded ondansetron.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells NAD+

Visit Bodi Envi

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.